These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38748660)

  • 21. A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Chohan K; Mittal N; McGillis L; Lopez-Hernandez L; Camacho E; Rachinsky M; Mina DS; Reid WD; Ryan CM; Champagne KA; Orchanian-Cheff A; Clarke H; Rozenberg D
    Chron Respir Dis; 2021; 18():14799731211025313. PubMed ID: 34291699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use and effectiveness of exercise for managing postural orthostatic tachycardia syndrome in young adults with joint hypermobility and related conditions: A scoping review.
    Peebles KC; Jacobs C; Makaroff L; Pacey V
    Auton Neurosci; 2024 Apr; 252():103156. PubMed ID: 38401460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
    Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
    Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
    Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
    Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urogenital and pelvic complications in the Ehlers-Danlos syndromes and associated hypermobility spectrum disorders: A scoping review.
    Gilliam E; Hoffman JD; Yeh G
    Clin Genet; 2020 Jan; 97(1):168-178. PubMed ID: 31420870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
    Yew KS; Kamps-Schmitt KA; Borge R
    Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Chuchin JD; Ornstein TJ
    Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Rashed ER; Ruiz Maya T; Black J; Fettig V; Kadian-Dodov D; Olin JW; Mehta L; Gelb BD; Kontorovich AR
    Vasc Med; 2022 Jun; 27(3):283-289. PubMed ID: 35000503
    [No Abstract]   [Full Text] [Related]  

  • 32. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos Syndrome/hypermobility spectrum disorder.
    Celletti C; Borsellino B; Castori M; Censi F; Calcagnini G; Camerota F; Strano S
    Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32434316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.
    Fairweather D; Bruno KA; Darakjian AA; Bruce BK; Gehin JM; Kotha A; Jain A; Peng Z; Hodge DO; Rozen TD; Munipalli B; Rivera FA; Malavet PA; Knight DRT
    Front Med (Lausanne); 2023; 10():1096180. PubMed ID: 37181352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative measures of tissue mechanics to detect hypermobile Ehlers-Danlos syndrome and hypermobility syndrome disorders: a systematic review.
    Palmer S; Denner E; Riglar M; Scannell H; Webb S; Young G
    Clin Rheumatol; 2020 Mar; 39(3):715-725. PubMed ID: 31955324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.
    Alsiri N; Alhadhoud M; Alkatefi T; Palmer S
    Semin Arthritis Rheum; 2023 Feb; 58():152127. PubMed ID: 36462303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
    Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Assessment of Nutrition and Dietary Influences in Hypermobile Ehlers-Danlos Syndrome-A Cross-Sectional Study.
    Topan R; Pandya S; Williams S; Ruffle JK; Zarate-Lopez N; Aziz Q; Fikree A
    Am J Gastroenterol; 2024 Apr; 119(4):727-738. PubMed ID: 37970870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular Symptoms, Dysautonomia, and Quality of Life in Adult and Pediatric Patients with Hypermobile Ehlers-Danlos Syndrome: A Brief Review.
    Hertel A; Black WR; Malloy Walton L; Martin J; Jones J
    Curr Cardiol Rev; 2024 Jan; 20(1):. PubMed ID: 38275067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.